UA100962C2 - Фармацевтипческой сустанции соли аминокислоты l-лизина и эсцина - Google Patents
Фармацевтипческой сустанции соли аминокислоты l-лизина и эсцинаInfo
- Publication number
- UA100962C2 UA100962C2 UAA201209844A UAA201209844A UA100962C2 UA 100962 C2 UA100962 C2 UA 100962C2 UA A201209844 A UAA201209844 A UA A201209844A UA A201209844 A UAA201209844 A UA A201209844A UA 100962 C2 UA100962 C2 UA 100962C2
- Authority
- UA
- Ukraine
- Prior art keywords
- escin
- salt
- amino acid
- lusine
- pharmaceutical substance
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940011399 escin Drugs 0.000 title abstract 2
- 229930186222 escin Natural products 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- AXNVHPCVMSNXNP-IVKVKCDBSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,9r,10r,12as,14ar,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(e)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(C[C@H]14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AXNVHPCVMSNXNP-IVKVKCDBSA-N 0.000 abstract 4
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 abstract 4
- YOSIWGSGLDDTHJ-UHFFFAOYSA-N isoescin Ia Natural products C12CC(C)(C)C(OC(=O)C(C)=CC)C(O)C2(COC(C)=O)C(O)CC(C2(CCC3C4(CO)C)C)(C)C1=CCC2C3(C)CCC4OC(C(C1O)OC2C(C(O)C(O)C(CO)O2)O)OC(C(O)=O)C1OC1OC(CO)C(O)C(O)C1O YOSIWGSGLDDTHJ-UHFFFAOYSA-N 0.000 abstract 4
- YOSIWGSGLDDTHJ-IVKVKCDBSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,9r,10r,12as,14ar,14br)-8a-(acetyloxymethyl)-8,9-dihydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(e)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hyd Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(COC(C)=O)[C@@H](O)[C@@H](C(C[C@H]14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YOSIWGSGLDDTHJ-IVKVKCDBSA-N 0.000 abstract 2
- YOSIWGSGLDDTHJ-OXPBSUTMSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,9r,10r,12as,14ar,14br)-8a-(acetyloxymethyl)-8,9-dihydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hyd Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(COC(C)=O)[C@@H](O)[C@@H](C(C[C@H]14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YOSIWGSGLDDTHJ-OXPBSUTMSA-N 0.000 abstract 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 2
- 235000019766 L-Lysine Nutrition 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к фармацевтике и касается фармацевтической субстанции, которая представляет собой соль аминокислоты L-лизина и эсцина, который представляет собой смесь эсцина Ia, эсцина Ib, изоэсцина Ia и изоэсцина Ib, где соотношение суммы эсцина Ia и эсцина Ib и суммы изоэсцина Ia и изоэсцина Ib составляет 2,0-9,0:8,0-1,0. Изобретение также касается фармацевтической композиции.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201209844A UA100962C2 (ru) | 2012-08-14 | 2012-08-14 | Фармацевтипческой сустанции соли аминокислоты l-лизина и эсцина |
| RU2012144715/15A RU2569353C2 (ru) | 2012-08-14 | 2012-10-19 | Фармацевтическая субстанция соли аминокислоты l-лизина и эсцина |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201209844A UA100962C2 (ru) | 2012-08-14 | 2012-08-14 | Фармацевтипческой сустанции соли аминокислоты l-лизина и эсцина |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA100962C2 true UA100962C2 (ru) | 2013-02-11 |
Family
ID=50515227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201209844A UA100962C2 (ru) | 2012-08-14 | 2012-08-14 | Фармацевтипческой сустанции соли аминокислоты l-лизина и эсцина |
Country Status (2)
| Country | Link |
|---|---|
| RU (1) | RU2569353C2 (ru) |
| UA (1) | UA100962C2 (ru) |
-
2012
- 2012-08-14 UA UAA201209844A patent/UA100962C2/ru unknown
- 2012-10-19 RU RU2012144715/15A patent/RU2569353C2/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2569353C2 (ru) | 2015-11-20 |
| RU2012144715A (ru) | 2014-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX358224B (es) | Composicion farmaceutica para el tratamiento y/o prevencion de cancer de higado. | |
| MX336038B (es) | Composiciones farmaceuticas de liberacion controlada de tapentadol. | |
| MX336682B (es) | Anticuerpos contra csf-1r humanos y usos de los mismos. | |
| IL233200A0 (en) | The history of alpha-boronic acid, its preparation and pharmaceutical preparations containing it | |
| EP4403579A3 (en) | Formulation for anti-alpha4beta7 antibody | |
| BRPI1014760B8 (pt) | preparação compreendendo insulina, nicotinamida e arginina | |
| MX356337B (es) | Anticuerpos contra csf-1r humano y sus usos. | |
| BR112014009031A2 (pt) | formulações de etanercept estabilizadas com íons de metais | |
| SG11201400769PA (en) | Quinolyl-containing Hydroxamic Acid Compound and Preparation Method Thereof, and Pharmaceutical Composition Containing This Compound and Use Thereof | |
| IN2015KN00262A (ru) | ||
| MY171146A (en) | Compositions of glp-1 peptides and preparation thereof | |
| EP4331667A3 (en) | Compositions comprising a delivery agent and preparation thereof | |
| EA201300388A1 (ru) | Соединения замещенного бензамида | |
| MX352245B (es) | Formulacion farmaceutica que comprende una droga biofarmaceutica. | |
| BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
| IN2014KN01607A (ru) | ||
| EA201200616A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
| MY168212A (en) | A new therapeutical composition containing apomorphine as active ingredient | |
| MX340147B (es) | Composiciones farmacéuticas y nutracéuticas del ácido abscísico. | |
| BR112013029730A2 (pt) | composição farmacêutica de rosuvastatina cálcica | |
| BR112014005935A2 (pt) | derivados de anilina, sua preparação e sua aplicação terapêutica | |
| BR112015000275A2 (pt) | utilização de um extrato de mirta como agente anti-biopelícula face p. acnes | |
| MX2014004210A (es) | Derivados de 2-oxo-piperidinilo. | |
| EP3132797A4 (en) | Use of composition containing iron (ii) amino acid chelate in preparation of drug for ameliorating diabetes | |
| UA103290C2 (ru) | Фармацевтическая композиция ибупрофена для инъекции |